pET-21a_2xNLS_LbCpf1_protein_expression Citations (3)
Originally described in: Editing aberrant splice sites efficiently restores beta-globin expression in beta-thalassemia.Xu S, Luk K, Yao Q, Shen AH, Zeng J, Wu Y, Luo HY, Brendel C, Pinello L, Chui DHK, Wolfe SA, Bauer DE Blood. 2019 Jan 31. pii: blood-2019-01-895094. doi: 10.1182/blood-2019-01-895094. PubMed Journal
Articles Citing pET-21a_2xNLS_LbCpf1_protein_expression
Articles |
---|
Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. Iyer S, Suresh S, Guo D, Daman K, Chen JCJ, Liu P, Zieger M, Luk K, Roscoe BP, Mueller C, King OD, Emerson CP Jr, Wolfe SA. Nature. 2019 Apr;568(7753):561-565. doi: 10.1038/s41586-019-1076-8. Epub 2019 Apr 3. PubMed |
Allosteric activation of CRISPR-Cas12a requires the concerted movement of the bridge helix and helix 1 of the RuvC II domain. Worle E, Newman A, D'Silva J, Burgio G, Grohmann D. Nucleic Acids Res. 2022 Sep 23;50(17):10153-10168. doi: 10.1093/nar/gkac767. PubMed |
RPA-CRISPR/Cas12a assay for the diagnosis of bovine Anaplasma marginale infection. Sutipatanasomboon A, Wongsantichon J, Sakdee S, Naksith P, Watthanadirek A, Anuracpreeda P, Blacksell SD, Saisawang C. Sci Rep. 2024 Apr 3;14(1):7820. doi: 10.1038/s41598-024-58169-6. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.